{"id":1241,"date":"2017-04-17T17:51:04","date_gmt":"2017-04-17T14:51:04","guid":{"rendered":"https:\/\/staging.iasispharma.com\/en\/?p=1241"},"modified":"2026-10-30T13:29:53","modified_gmt":"2026-10-30T11:29:53","slug":"iasis-pharma-participation-in-the-17th-hellenic-hypertension-conference","status":"publish","type":"post","link":"https:\/\/iasispharma.com\/en\/all-articles\/iasis-pharma-participation-in-the-17th-hellenic-hypertension-conference\/","title":{"rendered":"IASIS PHARMA PARTICIPATION IN THE 17th PANHELLENIC HYPERTENSION CONFERENCE"},"content":{"rendered":"<p><strong>MAKEDONIA PALACE HOTEL, THESSALONIKI,<\/strong> <strong>6-8\/4\/2017<\/strong><\/p>\n<p><strong>\u0399\u0391SIS PHARMA<\/strong> showed its active interest for the Field of Cardiology, by participating in the <strong>17th Panhellenic Hypertension Conference<\/strong> . The conference was organized by the <strong>Hellenic Hypertension Society<\/strong> (\u0395.\u03a5.\u03a5) and took place at <strong>Makedonia Palace Hotel<\/strong>, from <strong>April 6th to 8th<\/strong>, in <strong>Thessaloniki, Macedonia.<\/strong><\/p>\n<p>The event was addressed to doctors of various specializations that deal with the diagnosis and treatment of hypertension and also the prevention of cardiovascular diseases. Over 50 distinguished specialised scientists, from Greece and abroad, participated as speakers during the conference.<\/p>\n<p><strong>\u0399\u0391SIS PHARMA<\/strong> participated with an exhibition stand, where the attending physicians had the opportunity to be informed about the broad and high quality <strong>CVD portfolio<\/strong> of the company.<\/p>\n<p><strong>IASIS PHARMA<\/strong>, for the first time in a conference, presented<strong> Rami-Amlo\u00ae<\/strong> a new, original product, of a fixed-dose combination (F.D.C.) of <strong>Ramipril + Amlodipine<\/strong> in (10+5)mg, (5+10)mg, (5+5)mg dosages, offered also in the unique F.D.C. of Ramipril+Amlodipine (10+10)mg.<\/p>\n<p>Apart from <strong>Rami-Amlo\u00ae<\/strong>, <strong>IASIS PHARMA<\/strong> also presented other key products from its CVD range, such as <strong>Licepler\u00ae, eplerenone<\/strong>, the first generic eplerenone marketed in Greece by a Greek Pharmaceutical Company and <strong>Avalsan\u00ae\/Avalsan plus\u00ae (valsartan\/+\u0397CTZ)<\/strong>, the first generic valsartan available in the Greek market.<\/p>\n<p><img decoding=\"async\" class=\"alignnone size-medium wp-image-1304\" src=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2017\/04\/ypertasi-17-1-300x207.jpg\" alt=\"ypertasi-17-1\" width=\"300\" height=\"207\" srcset=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2017\/04\/ypertasi-17-1-120x83.jpg 120w, https:\/\/iasispharma.com\/wp-content\/uploads\/2017\/04\/ypertasi-17-1-200x138.jpg 200w, https:\/\/iasispharma.com\/wp-content\/uploads\/2017\/04\/ypertasi-17-1-300x207.jpg 300w, https:\/\/iasispharma.com\/wp-content\/uploads\/2017\/04\/ypertasi-17-1-400x276.jpg 400w, https:\/\/iasispharma.com\/wp-content\/uploads\/2017\/04\/ypertasi-17-1-500x344.jpg 500w, https:\/\/iasispharma.com\/wp-content\/uploads\/2017\/04\/ypertasi-17-1-600x413.jpg 600w, https:\/\/iasispharma.com\/wp-content\/uploads\/2017\/04\/ypertasi-17-1-700x482.jpg 700w, https:\/\/iasispharma.com\/wp-content\/uploads\/2017\/04\/ypertasi-17-1-768x529.jpg 768w, https:\/\/iasispharma.com\/wp-content\/uploads\/2017\/04\/ypertasi-17-1.jpg 800w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/> \u00a0\u00a0 <img decoding=\"async\" class=\"alignnone size-medium wp-image-1306\" src=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2017\/04\/ypertasi-17-2-300x226.jpg\" alt=\"ypertasi-17-2\" width=\"300\" height=\"226\" srcset=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2017\/04\/ypertasi-17-2-120x90.jpg 120w, https:\/\/iasispharma.com\/wp-content\/uploads\/2017\/04\/ypertasi-17-2-200x151.jpg 200w, https:\/\/iasispharma.com\/wp-content\/uploads\/2017\/04\/ypertasi-17-2-300x226.jpg 300w, https:\/\/iasispharma.com\/wp-content\/uploads\/2017\/04\/ypertasi-17-2-400x302.jpg 400w, https:\/\/iasispharma.com\/wp-content\/uploads\/2017\/04\/ypertasi-17-2-500x377.jpg 500w, https:\/\/iasispharma.com\/wp-content\/uploads\/2017\/04\/ypertasi-17-2-600x452.jpg 600w, https:\/\/iasispharma.com\/wp-content\/uploads\/2017\/04\/ypertasi-17-2-700x528.jpg 700w, https:\/\/iasispharma.com\/wp-content\/uploads\/2017\/04\/ypertasi-17-2.jpg 744w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>MAKEDONIA PALACE HOTEL, THESSALONIKI, 6-8\/4\/2017 \u0399\u0391SIS PHARMA showed its active interest for the Field of Cardiology, by participating in the 17th Panhellenic Hypertension Conference . The conference was organized by the Hellenic Hypertension Society (\u0395.\u03a5.\u03a5) and took place at Makedonia Palace Hotel, from April 6th to 8th, in Thessaloniki, Macedonia. The event was addressed to  [&#8230;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":true,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[33,157],"tags":[],"class_list":["post-1241","post","type-post","status-publish","format-standard","hentry","category-all-articles","category-press-room-en"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7HJeP-k1","jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/1241","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/comments?post=1241"}],"version-history":[{"count":5,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/1241\/revisions"}],"predecessor-version":[{"id":1310,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/1241\/revisions\/1310"}],"wp:attachment":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/media?parent=1241"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/categories?post=1241"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/tags?post=1241"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}